Design, Synthesis, In Vitro Biological Evaluation, and In Silico Studies of Novel Imidazo[4,5-b]Pyridine-Acrylonitrile-Based Derivatives as VEGFR-2 Inhibitors Against Breast Cancer and Hepatocellular Carcinoma. [PDF]
Mohamed LW, Saadeldin AA, Farag AB.
europepmc +1 more source
From Synthesis to Mechanism: Biological Evaluation of a p-Toluidine-Based Thiazolidinone-Quinoline VEGFR-2 Candidate Supported by CADD. [PDF]
Manni E +7 more
europepmc +1 more source
Clinical efficacy and safety of apatinib plus S-1 combined with oxaliplatin (SOX) in postoperative stage III gastric cancer patients with high VEGFR-2 expression. [PDF]
Deng Q +11 more
europepmc +1 more source
Design, Synthesis, Molecular Docking, and Anticancer Activity of Chalcone Derivatives as VEGFR-2 Inhibitors. [PDF]
Yu M, Zhang X, Zhu H, Zhang X.
europepmc +1 more source
IL-10 secretion by CD8 T cells orchestrates early NK cell recruitment and antitumor immunity after anti-VEGFR-2/PD-1 therapy. [PDF]
Geindreau M +20 more
europepmc +1 more source
Exploring market-approved azoles as potential breast cancer therapeutics targeting the VEGFR-2 biotarget. [PDF]
Atta AM +13 more
europepmc +1 more source
Expression of Concern: Dietary Compound Isoliquiritigenin Inhibits Breast Cancer Neoangiogenesis via VEGF/VEGFR-2 Signaling Pathway. [PDF]
PLOS One Editors.
europepmc +1 more source
Potential Application of Cocoa Extract in Preventing Skin Cancer Through Inhibition of Adenosine Receptor A2, VEGFR-2, and BCL-2: <i>in vivo</i> and Docking Molecular Studies. [PDF]
Wahab S, Djawad K.
europepmc +1 more source
Therapeutic Targeting of VEGFR-2, PD-L1, and EGFR-MET Pathways in Non-Small Cell Lung Cancer: Clinical Progress with Ramucirumab, Atezolizumab, and Amivantamab. [PDF]
Kawczak P, Bączek T.
europepmc +1 more source
In Silico Molecular Docking and Pharmacokinetic Evaluation of Cannabinoid Derivatives as Multi-Target Inhibitors for EGFR, VEGFR-1, and VEGFR-2 Proteins. [PDF]
Ayoobi A, Choi HW.
europepmc +1 more source

